Showing results (2071-2080 of 2,113) with videos related to

Sort By:
Pageof 212
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 4, 2024
Phase III Randomized, Placebo-Controlled Trial of Endocrine Therapy ± 1 Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive, Early-Stage Breast CancerMariana Chavez-MacGregor, Jieling Miao, Lajos Pusztai, et al.
The New England Journal of Medicine|March 12, 2019
Sleep and Alertness in a Duty-Hour Flexibility Trial in Internal MedicineMathias Basner, David A Asch, Judy A Shea, et al.
The American Journal of Gastroenterology|February 4, 2006
Serum immune responses predict rapid disease progression among children with Crohn's disease: immune responses predict disease progressionMarla C Dubinsky, Ying-Chao Lin, Debra Dutridge, et al.
The New England Journal of Medicine|March 21, 2018
Education Outcomes in a Duty-Hour Flexibility Trial in Internal MedicineSanjay V Desai, David A Asch, Lisa M Bellini, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 16, 2008
Increased immune reactivity predicts aggressive complicating Crohn's disease in childrenMarla C Dubinsky, Subra Kugathasan, Ling Mei, et al.
Neurology|October 11, 2013
MRI and pathology of REM sleep behavior disorder in dementia with Lewy bodiesMelissa E Murray, Tanis J Ferman, Bradley F Boeve, et al.
BMJ Open|February 5, 2024
Efficacy and safety of autologous haematopoietic stem cell transplantation versus alemtuzumab, ocrelizumab, ofatumumab or cladribine in relapsing remitting multiple sclerosis (StarMS): protocol for a randomised controlled trialGavin Brittain, Jennifer Petrie, Kate E M Duffy, et al.
Current Topics in Medicinal Chemistry|November 29, 2013
Collaborative development of 2-hydroxypropyl-β-cyclodextrin for the treatment of Niemann-Pick type C1 diseaseElizabeth A Ottinger, Mark L Kao, Nuria Carrillo-Carrasco, et al.
Cell Host & Microbe|April 14, 2022
Colonization of the live biotherapeutic product VE303 and modulation of the microbiota and metabolites in healthy volunteersMelissa Dsouza, Rajita Menon, Emily Crossette, et al.
Scientific Reports|February 24, 2018
Human mitochondrial pyruvate carrier 2 as an autonomous membrane transporterRaghavendra Sashi Krishna Nagampalli, José Edwin Neciosup Quesñay, Douglas Adamoski, et al.
Pageof 212